Hikma Pharmaceuticals PLC hit a new 52-week high, surpassing its previous peak of £21.84, which the company achieved on ...

Hikma Pharmaceuticals (LON:HIK – Free Report) had its price objective lifted by Berenberg Bank from GBX 2,400 ($29.74) to GBX 2,560 ($31.73) in a research note published on Wednesday morning, ...

M42, a global health leader powered by artificial intelligence (AI), and Hikma Pharmaceuticals PLC (Hikma), announced the signing of a strategic memorandum of understanding (MOU), to accelerate the ...

Hikma Pharmaceuticals PLC (Hikma), the multinational Pharmaceutical group, today announces that it has signed a strategic memorandum of understanding (MOU) with M42, a global health leader powered by ...

Guardant Health (GH) announced an agreement with the Abu Dhabi Public Health Center ADPHC to introduce a non-invasive blood-based screening ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced an agreement with the Abu Dhabi ...

Hikma Pharmaceuticals PLC HIK shares advanced 1.97% to £21.72 Monday, on what proved to be an all-around positive trading ...

Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical group, today announces that it has entered an exclusive commercial partnership with Emergent BioSolutions (Emergent) for the ...